Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Short-term Investments: 2022-2025

Historic Short-term Investments for Harmony Biosciences Holdings (HRMY) over the last 4 years, with Sep 2025 value amounting to $25.6 million.

  • Harmony Biosciences Holdings' Short-term Investments rose 10.70% to $25.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.6 million, marking a year-over-year increase of 10.70%. This contributed to the annual value of $14.2 million for FY2024, which is 66.06% down from last year.
  • According to the latest figures from Q3 2025, Harmony Biosciences Holdings' Short-term Investments is $25.6 million, which was up 33.07% from $19.2 million recorded in Q2 2025.
  • In the past 5 years, Harmony Biosciences Holdings' Short-term Investments ranged from a high of $79.3 million in Q4 2022 and a low of $14.2 million during Q4 2024.
  • In the last 3 years, Harmony Biosciences Holdings' Short-term Investments had a median value of $29.6 million in 2024 and averaged $33.3 million.
  • Its Short-term Investments has fluctuated over the past 5 years, first surged by 203.71% in 2023, then slumped by 66.06% in 2024.
  • Over the past 4 years, Harmony Biosciences Holdings' Short-term Investments (Quarterly) stood at $79.3 million in 2022, then tumbled by 47.31% to $41.8 million in 2023, then slumped by 66.06% to $14.2 million in 2024, then increased by 10.70% to $25.6 million in 2025.
  • Its last three reported values are $25.6 million in Q3 2025, $19.2 million for Q2 2025, and $18.0 million during Q1 2025.